Abstract
The phosphodiesterase inhibitor, ibudilast ameliorates Huntington's disease pathology by modulating neuroinflammation and signaling pathway in a rat model
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have